Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDB-2914 for Uterine Leiomyomata
NCT00044876Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Sep 2002
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ulipristal in uterine leiomyoma (3 arms), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Change in fibroid size. Started Sep 2002; status: completed.
02
Drugs
ulipristal
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT00044876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044876.